Free database of papers and journals






Results 1 to 20 of 1,122 articles found
2020

Rapid desensitization of hydroxychloroquine

Annals of Allergy, Asthma, & Immunology (1.1 109), 124, 97-98.
1988

Hydroxychloroquine in steroid dependent asthma

Pulmonary Pharmacology (39), 1, 59-61.
2020

Hydroxychloroquine and Potential Drug Interactions in Older Adults

Archivos De Bronconeumología (0.2 47), 56, 679-681.
2018

Hydroxychloroquine as a steroid-sparing agent in an infant with chronic urticaria

Annals of Allergy, Asthma, & Immunology (1.1 109), 120, 102-104.
2014

[Case Report] Ten-year follow up of hydroxychloroquine treatment for ABCA3 deficiency

Pediatric Pulmonology (2.3 108), 49, 299-301.
2015

[Review] Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases

Pediatric Pulmonology (2.3 108), 50, 410-419.
2020

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

The Lancet Respiratory Medicine (6.8 141), 8, 539-541.
2015

Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency

Annals of Allergy, Asthma, & Immunology (1.1 109), 114, 68-70.
2003

Cellular Interstitial Pneumonitis in Children: Response to Hydroxychloroquine Treatment in Two Cases

1997

Hydroxychloroquine therapy of diffuse pulmonary sarcoidosis in two Australian male children

Respirology (0.7 89), 2, 71-74.
2021

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial

2020

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials

Archivos De Bronconeumología (0.2 47), 56, 606-608.
2020

Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19

2007

Oral hydroxychloroquine desensitization in a 50 year old male with cutaneous lupus

The World Allergy Organization Journal (3.4 45), &NA;, S265-S266.
2020

[Discussion] Chloroquine and hydroxychloroquine for COVID-19: A word of caution

Respirology (0.7 89), 25, 683-684.
2021

Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19

2020

Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial

2006

Delayed hypersensitivity to hydroxychloroquine manifested by two different types of cutaneous eruptions in the same patient

Allergologia Et Immunopathologia (1.4 31), 34, 174-175.
2020

The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis

Canadian Respiratory Journal (1.9 50), 2020, 1-16.
2018

Hydroxychloroquine-induced cardiomyopathy and heart failure in twins

Journal of Thoracic Disease (1.6 45), 10, E70-E73.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions